Sanofi Pasteur, A Sanofi Company

This study tests an mRNA vaccine designed to fight acne. Researchers will give two shots to 120 adults aged 18 to 45 with mild acne. The goal is to see if the vaccine is safe and reduces pimples. Participants are randomly assigned to receive the vaccine or a placebo.

This study tests an experimental mRNA vaccine designed to treat moderate to severe acne in adults aged 18 to 45. The vaccine is given as up to three injections into the muscle. Researchers will monitor safety, immune response, and how well it reduces acne lesions. The trial invol…

This study tracks 500 pregnant women in the US who received the Dengvaxia dengue vaccine. Researchers will monitor mothers and their babies for any side effects or pregnancy complications. The goal is to gather safety data, not to test the vaccine's effectiveness.

This study monitors the safety of the MenQuadfi vaccine when given to pregnant women or within 30 days before their last period. Researchers will track side effects in mothers and health outcomes in babies, including birth defects and complications. About 50 women in the U.S. wil…